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INTRODUCTION
Many patients have been suffering from severe liver diseases 
such as hepatocellular carcinoma, liver cirrhosis from chronic 
viral hepatitis and alcoholic liver disease. So many treatments 
have been developed for decades for the patients having serious 
liver diseases. Liver transplantation is an effective therapeutics 
options for chronic liver diseases. However, it is limited by 
donor organ shortage, surgical complications and the risk of 
rejection [1]. Recently, artificial livers have been considered as 
an alternative for liver transplantation. The major obstacle to 
this is that primary hepatocytes cannot be cultured for a long 
time. Commonly hepatocytes are differentiated into fibroblast­
like after isolated 3–5 days and turned on the cell death 
program [2]. Hence, long­term culture of hepatocytes is the 
main problem that has to be resolved to be able to make bionic 
Purpose: The major problem in producing artificial livers is that primary hepatocytes cannot be cultured for many days. 
Recently, 3-dimensional (3D) printing technology draws attention and this technology regarded as a useful tool for current 
cell biology. By using the 3D bio-printing, these problems can be resolved.
Methods: To generate 3D bio-printed structures (25 mm × 25 mm), cells-alginate constructs were fabricated by 3D bio-
printing system. Mouse primary hepatocytes were isolated from the livers of 6–8 weeks old mice by a 2-step collagenase 
method. Samples of 4 × 107 hepatocytes with 80%–90% viability were printed with 3% alginate solution, and cultured with 
well-defined culture medium for primary hepatocytes. To confirm functional ability of hepatocytes cultured on 3D alginate 
scaffold, we conducted quantitative real-time polymerase chain reaction and immunofluorescence with hepatic marker 
genes.
Results: Isolated primary hepatocytes were printed with alginate. The 3D printed hepatocytes remained alive for 14 days. 
Gene expression levels of Albumin, HNF-4α and Foxa3 were gradually increased in the 3D structures. Immunofluorescence 
analysis showed that the primary hepatocytes produced hepatic-specific proteins over the same period of time.
Conclusion: Our research indicates that 3D bio-printing technique can be used for long-term culture of primary 
hepatocytes. It can therefore be used for drug screening and as a potential method of producing artificial livers.
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livers.
Currently, 3­dimensional (3D) printing technology plays an 
important role in tissue engineering. Principle of 3D printing is 
that a computer recognizes a 3D model and slices it into a series 
of 2­dimensional (2D) sections, which in then printed from 
bottom to the top. This method has the advantage that it can 
print any desired shape. It can be used in biological applications 
since several cellular matrixes, such as collagen, alginate, etc., 
are available to which cells can attach. 
Many reports suggested that 3D cultures are superior to 
2D cultures in previous studies [3]. In this report, we printed 
primary hepatocytes using a 3D bio printer and compared 
their functions. By using the 3D bio­printing, drawback of 
primary hepatocytes that make long­term culture difficulty 
can be resolved. And it can be one of the possible options for 
bioartificial liver.
METHODS
Isolation of mouse primary hepatocytes
Primary hepatocytes were isolated from 6–8 week mouse 
livers by a 2­step collagenase perfusion method [4]. Briefly, A 
and B solution had almost same compositions except presence 
of ethylenediaminetetraacetic acid (EDTA) in solution A. EDTA 
in solution A was calcium chelating agent and solution B was 
comprises of many compounds including collagenase and 
trypsin inhibitor for isolate primary hepatocytes from liver 
tissues. After sequential flows of solution A for 5 minutes 
and solution B for 8 minutes at 37oC, livers were removed and 
chopped up in a dish. After percoll treatment, we obtain 4 × 107 
hepatocytes with 80%–90% viability. The primary hepatocytes 
were cultured in Williams’ Medium E (Gibco, Grand Island, 
NY, USA) supplemented with 0.1mM dexamethasone, 0.5% 
penicillin/streptomycin, 1% ITS, 5mM GlutaMAX (Gibco) and 
15mM HEPES (N­2­hydroxyethylpiperazine­N­2­ethanesulfonic 
acid) at 37oC in a 5% CO2 incubator. The medium was changed 
every 2 days.
Fabrication of cells-alginate constructs
The cells­alginate constructs were fabricated using 3D bio­
printing system (Korea Institute of Machinery and Materials, 
Daejeon, Korea). The 3D printing system consisted of a 
computer­aided system with a 3­axes stage, syringe, nozzle, 
and pressure controller. To fabricate the hydrogel constructs, 
3% alginate was dissolved in cell medium solution. Cells­
alginate hydrogels were ejected through the nozzle layer­by­
layer. Hydrogel porous patterns of strand thickness and space 
were controlled by pressure and velocity. 4 × 107 hepatocytes 
were blended with 3% alginate solution and 1% calcium 
chloride. The 3D bio­printed structures measured 25 mm × 
25 mm and consisted of 7 layers. After printing, the scaffolds 
were incubated in 5% calcium chloride solution for 10 seconds 
cross­linking and washed with phosphate buffered saline (PBS) 
(WELGENE, Gyengsan, Korea). After washing, the alginate 
scaffolds with primary hepatocytes were incubated in culture 
medium.
Quantitative real-time polymerase chain reaction 
Total RNAs were isolated with TRIzol Reagent (Ambion, 
Foster City, CA, USA) with chloroform. 1­mg samples of RNA 
were reverse transcribed using a Transcriptor First Strand 
cDNA Synthesis Kit (Roche, Mannheim, Germany). Real­time 
polymerase chain reaction (PCR) was conducted using 1 mg of 
cDNA, 10 mg of quantitative PCR PreMix (Dyne bio, Seongnam, 
Korea), and oligonucleotide primers. The primers are shown 
at Table 1 (mouse Albumin, HNF­4α , Foxa3, ASGR1 and U6). 
The PCR cycles consisted of 40 cycles of 95oC for 20 seconds 
and 60oC for 40 seconds. Melting curves were constructed to 
characterize the PCR products.
Hematoxylin & eosin staining 
Alginate scaffolds were embedded in Optimal Cutting 
Tem perature Compound (Sakura Finetek, Tokyo, Japan) and 
sectioned at 4­mm thickness. Sections were fixed with 95% 
ethanol for 5 minutes. After fixation, sections were washed 
with DW for 5 minutes. After washing, sections were stained 
with hematoxylin for 3 minutes and washed with DW for 1 
minute. Next, sections were counterstained with eosin for 1 
minute and washed with running water for 5 minutes and 
sections were dehydrated with 50% ethanol for 3 minutes, 70% 
ethanol for 3 minutes, 95% ethanol for 3 minutes and 100% 
ethanol for 3 minutes. Finally, sections were immersed with 
xylene and mounted with mounting solution (Southern Biotech, 
Birmingham, UK).
Immunofluorescence
Alginate scaffolds were sectioned as above, fixed in acetone 
for 15 minutes and dried for 5 minutes. After washing with 
Table 1. Oligonucleotide primers for real­time polymerase 
chain reaction
Gene Primer Primer sequence (5’­3’)
Albumin Forward GGCTACAGCGGAGCAACTGA
Reverse GCCTGAGAAGGTTGTGGTTGTG
HNF­4α Forward ATCGTCAAGCCTCCCTCTGC
Reverse GACTGGTCCCTCGTGTCACATC
Foxa3 Forward CTCCTTCGTCCACACCTTATTT
Reverse AAGGTGTCGATGTCTGTTCTG
ASGR1 Forward CAGCTCTGTGAGGCCTTGGA
Reverse GGGCCCGTTCTGGTCAGTTA
U6 Forward CTCGCTTCGGCAGCACA
Reverse AACGCTTCACGAATTTGCGT
 Annals of Surgical Treatment and Research 69
PBS buffer they were incubated with primary antibodies, anti­
goat serum albumin antibody (ab19194, Abcam, Cambridge, 
MA, USA) and anti­mouse monoclonal cytokeratin 18 antibody 
(ab668, Abcam), at 4oC overnight each was diluted 1:100. 
After incubation, sections were washed 3 times with PBS. The 
sections were then incubated with Hoechst 33342 (H3570, 
Life Technologies, Eugene, OR, USA) was diluted 1:10,000, 
followed by secondary antibodies, 594 donkey anti­goat (A11058, 
Life technologies) and 488 donkey anti­mouse (A21202, Life 
technologies) at room temperature for 1 hour each diluted 
1:250. After incubation, sections were washed 3 times with 
staining solution and PBS. Finally, sections were mounted with 
mounting solution.
RESULTS 
Isolation of primary hepatocytes & 3D alginate 
scaffold application
For 3D printing of primary hepatocytes, we isolated mouse 
hepatocytes by collagenase perfusion method. Perfusion 
solutions A and B were injected through the mouse portal 
vein (Fig. 1A, B). The following day, polygonal and binuclear 
hepatocytes could be seen attached onto collagen coated dishes 
(Fig. 1C).
In general, primary hepatocytes cannot be cultured for more 
than 2 days without loss of function. Therefore, to see whether 
hepatocytes could multiply for longer in the 3D structures, 4 × 
107 hepatocytes were mixed with 3% alginate solution and 1% 
calcium chloride. The 3D bio­printed structures measured 25 
mm × 25 mm and had 7 layers (Fig. 1D, E). 
The 3D printed hepatocytes were observed for 14 days in 
hepatocyte culture medium. On day 1, the primary hepatocytes 
were present in twos and threes within the alginate construct 
(Fig. 2A, B), but by day 3 they were had formed aggregates that 
expanded in time. These phenomena cannot present on 2D 
culture system. Seven days after culture, primary hepatocytes 
were assembled more and more as time passes (Fig. 2C–E). 
And this aggregates were found at many locations in alginate 
scaffold. These results suggest that primary hepatocytes printed 
with alginate, can be cultured for more than 2 weeks and create 
in vivo like hepatocyte masses. 
Expression of hepatic genes in the 3D constructs
A key question concerning 3D printing of primary hepato­
cytes is whether they maintain hepatic function. We therefore 
examined the expression of four major marker genes by quan­
titative real­time PCR albumin, hepatocyte nuclear fac tor 4 
alpha (HNF­4α), forkhead box protein A3 (Foxa3), and asialo­
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A B C D E
Fig. 1. Perfusion for isolation of primary hepatocytes and 3­dimensional (3D) bio­printing. To obtain primary hepatocytes, we 
uses a 2­step perfusion method, in which perfusion solution is injected through the portal vein (A, B). Panel B is a magnification 
of panel A and the red arrow indicates portal vein. Panel C shows primary hepatocytes cultured for 1 day. The 3D bio­printer 
can print the alginate and hepatocyte mixture with air pressure (D). Seven layered 3D bio­hepatic structures were printed (E; 
25 mm × 25 mm).
Fig. 2. (A­D) Morphological change with time of primary hepatocytes cultured in 3­dimensional (3D) alginate scaffold. Three­
dimensional printed hepatocytes migrated and aggregated for 14 days. In addition, they aggregated 3D hepatocyte structures 
after 7 days (arrow in D, E). Panel E is magnified region of Panel D.
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Fig. 3. Gene expression in primary hepatocytes cultured by 3­dimensional (3D) bio­printing. Albumin (A), HNF­4α (B), and 
Foxa3 (C) gradually increased with time. (D) ASGR1 expression decreased slightly on day 14. Expression continued for at least 
14 days. MEF, mouse embryonic fibroblasts.
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Fig. 4. Immunofluorescence detection of hepatic­specific proteins. (A, G, and M) The photo of hematoxilin & eosin (H&E) 
staining, and (B, H, N) black box is a magnified region . Panels A to R are hepatocytes morphology in 3­dimensional scaffold, 
and immunofluorescence photo of hepatocyte specific protein (albumin and cytokeratin 18 [CK18]) shows in panels C­F, I­L, 
and O­R with time.
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glycoprotein receptor 1 (ASGR1). As shown in Fig. 3, expression 
of these genes increased gradually up to day 14, though expres­
sion of ASGR1 fell on day 14 (Fig. 3D). 
We also stained the 3D printed hepatocytes with hematoxylin 
& eosin staining (H&E), and examined the production of hepatic­
specific proteins by immunofluorescence analysis. H&E staining 
showed that the primary hepatocytes maintained their normal 
appearance up to day 14 (Fig. 4A, B, G, H, M, N). Albumin and 
cytokeratin 18 could also be demonstrated up to day 14 (Fig. 
4C–F, I–L, O–R). Taken together these findings indicate that 
functions of isolated primary hepatocytes are maintained 
in the 3D alginate constructs, and suggest the possibility of 
manufacturing artificial livers using 3D bio­printing techniques.
DISCUSSION
Researches of primary hepatocytes have been briskly pro­
ceeded to detect hepatic uptake and metabolism [5]. The hepatic 
functions of primary hepatocytes such as secretion of albumin, 
synthesis of urea, and expression of CYP3A4 have usually been 
used in drug screening study [6]. But primary hepatocytes 
quickly decrease hepatic functions when they are isolated from 
the tissues [7,8]. Previous studies have demonstrated the effect 
that culture conditions such as the culture media, supplements 
of media, extracellular matrix and collagen gel sandwich 
methods [9].
Recently, many researcher use 3D bio­printing for improve 
culture systems. 3D printing considers a diverse of processes for 
manufacturing 3D objects from a 3D models or electronic data 
sources. First, 3D models or electronic data sources are split 
to many slices and stacking by the layers. In the near future, 
we can make bio­printed livers by 3D printing technology [10]. 
For applications of therapeutic into human, the typical process 
of bio­printing would cover the isolation and enlargement of 
human cells beforehand printing the scaffold. Scaffolds printed 
bio­printing could eventually be used as devices of therapeutic 
such as a platform of testing for drug screening and discovery, 
or an in vitro model system for disease [3].
Alginates are naturally obtainable glycans that easily form 
hydrogels [11]. They consist of α­L­glucuronic acid monomers 
and (1­4)­linked β­D­mannuronic acid that form polymer 
chains [12]. Divalent cations such as Ca2+ promote crosslinking 
by binding between the regions of sequential α­L­guluronic 
acid. This makes alginate scaffolds maintain the desired 
shape. Alginate has been use for 3D cell culture and cell trans­
plantation and is bio­degradable. Alginate scaffolds are reported 
to be suitable for studying cell­ligand interactions owing to the 
low protein assimilation of the anionic polysac charide [13]. 
Primary hepatocytes form characteristic aggregate when 
cultured in organ systems [14]. Up 7 days, primary hepatocytes 
cultured in the 3D alginate scaffolds existed as single cell. 
After 7 days, they show gradually agglomerated, and their 
morphology suggested such as albumin synthesis [14]. These 
findings indicated that primary hepatocytes in printed 3D 
scaffolds were stable and retained hepatic­function.
After isolation, primary hepatocytes quickly dedifferentiate 
in 2D culture system, losing hepatic function and remaining 
viable for only a short time. Expression of hepatic genes 
therefore steadily declines [15]. However, our investigation has 
shown above that hepatocyte function is retained for up to 14 
days in the 3D alginate scaffolds. 
Up to now, the collagen sandwich method has been the best 
technology for culturing primary hepatocyte. The system is 
better than 3D bio­printing, for observation of morphological 
changes, while retention of function is similar in the 2 systems.
In conclusion, the advantages of 3D bio­printing are the 
ability to control the cell distribution, its high scalability 
and the ability to form desired shapes. This technique has 
enormous potential in tissue engineering and for make micro 
unit of complex in bio­medical area.
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